Literature DB >> 6837584

Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus.

W A Pulsinelli, D E Levy, B Sigsbee, P Scherer, F Plum.   

Abstract

Animal experiments employing controlled degrees of cerebral ischemia have demonstrated that elevated blood-brain glucose concentrations greatly enhance the extent and degree of subsequent brain damage. The question of whether or not a similar relationship applies in man was examined by retrospectively segregating patients admitted with the diagnosis of ischemic stroke into diabetic (n = 35) and nondiabetic (n = 72) groups. A separate nondiabetic population with ischemic stroke was prospectively analyzed by dividing patients into those with an admission blood glucose level above (n = 14) or below (n = 17) 120 mg/dl. The neurologic status at discharge was used to stratify outcome as good, fair, or poor in the retrospective study. The ability or inability to return to work was used to separate good and poor outcomes in the prospective study. Neurologic outcome in diabetic patients with stroke was significantly worse (p less than 0.05) than in nondiabetic patients, and the diabetic patients had a greater (p less than 0.05) number of stroke-related deaths. In the prospective study, neurologic outcome also was worse with high blood sugar levels, only 43 percent of the patients with blood glucose values above 120 mg/dl returned to work, whereas 76 percent of those with lower blood sugar values regained employment (p = 0.061).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6837584     DOI: 10.1016/0002-9343(83)91007-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  72 in total

1.  The effects of intraoperative glucose infusion on portal blood insulin concentration and hepatic mitochondrial redox state during surgery: comparison of short-term and continuous infusions.

Authors:  J Hayakawa; H Motohashi; M Sairenji; O Kobayashi; M Takahashi; Y Usuda
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  Convulsive Status Epilepticus.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-09       Impact factor: 3.598

3.  [Recommendations of the European Stroke Initiative (EUSI) for treatment of ischemic stroke--update 2003. I. organization and acute therapy].

Authors:  Sonja Külkens; Peter Arthur Ringleb; Werner Hacke
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

4.  Impact of diabetes on prolonged hospital stay among Native Hawaiians and other Pacific Islanders with ischemic stroke.

Authors:  Kazuma Nakagawa; Megan A Vento; Marissa M Ing; Susan M Asai
Journal:  Hawaii J Med Public Health       Date:  2014-12

5.  Light and electron microscopic evaluation of hydrogen ion-induced brain necrosis.

Authors:  C K Petito; R P Kraig; W A Pulsinelli
Journal:  J Cereb Blood Flow Metab       Date:  1987-10       Impact factor: 6.200

Review 6.  Risk factors in stroke.

Authors:  P Mustacchi
Journal:  West J Med       Date:  1985-08

7.  Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats.

Authors:  Ashish K Rehni; Vibha Shukla; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Neuropharmacology       Date:  2018-03-15       Impact factor: 5.250

8.  Acetylcholinesterase inhibitor ENA-713 protects against ischemia-induced decrease in pre- and postsynaptic cholinergic indices in the gerbil brain following transient ischemia.

Authors:  K Tanaka; N Ogawa; K Mizukawa; M Asanuma; Y Kondo; S Nishibayashi; A Mori
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

9.  The prognostic value of blood glucose and glycosylated haemoglobin estimation in patients with stroke.

Authors:  N H Cox; J W Lorains
Journal:  Postgrad Med J       Date:  1986-01       Impact factor: 2.401

Review 10.  Inpatient Glycemic Management of Non-cardiac CVD: Focus on Stroke and PVD.

Authors:  Estelle Everett; Nestoras Mathioudakis
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.